Rocket Pharmaceuticals treats first patient in phase 1 trial of RP-L301 for PKD

Rocket Pharmaceuticals treats first patient in phase 1 trial of RP-L301 gene therapy for PKD.(Credit: Mahmoud Ahmed from Pixabay)